These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 13678392)
1. Renal failure caused by eyedrops containing phenylephrine in a case of retinopathy of prematurity. Shinomiya K; Kajima M; Tajika H; Shiota H; Nakagawa R; Saijyou T J Med Invest; 2003 Aug; 50(3-4):203-6. PubMed ID: 13678392 [TBL] [Abstract][Full Text] [Related]
2. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants. Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737 [TBL] [Abstract][Full Text] [Related]
4. Systemic adverse events after screening of retinopathy of prematurity with mydriatic. Obata S; Imamura T; Kakinoki M; Yanagi T; Maruo Y; Ohji M PLoS One; 2021; 16(9):e0256878. PubMed ID: 34499693 [TBL] [Abstract][Full Text] [Related]
5. The local vasoconstriction of infant's skin following instillation of mydriatic eye drops. Alpay A; Ermis B; Ugurbas SC; Battal F; Sagdik HM Eur J Clin Pharmacol; 2010 Nov; 66(11):1161-4. PubMed ID: 20835704 [TBL] [Abstract][Full Text] [Related]
6. Fatal necrotising enterocolitis due to mydriatic eye drops. Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272 [TBL] [Abstract][Full Text] [Related]
7. [Serious adverse side effects after pupillary dilation in preterm infants]. Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252 [TBL] [Abstract][Full Text] [Related]
8. Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates. Kremer LJ; Broadbent R; Medlicott N; Sime MJ; McCaffrey F; Reith DM Arch Dis Child; 2021 Jun; 106(6):603-608. PubMed ID: 33051215 [TBL] [Abstract][Full Text] [Related]
9. Alternative mydriasis techniques for retinopathy of prematurity screening. Seliniotaki AK; Prousali E; Lithoxopoulou M; Kokkali S; Ziakas N; Soubasi V; Mataftsi A Int Ophthalmol; 2020 Dec; 40(12):3613-3619. PubMed ID: 32772218 [TBL] [Abstract][Full Text] [Related]
10. Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant. Degirmencioglu H; Oncel MY; Calisici E; Say B; Uras N; Dilmen U J Pediatr Ophthalmol Strabismus; 2014 Jul; 51 Online():e44-7. PubMed ID: 25003832 [TBL] [Abstract][Full Text] [Related]
11. The effects of mydriatic eye drops on cerebral blood flow and oxygenation in retinopathy of prematurity examinations. Kara N; Arman D; Seymen Z; Eratlı G; Gül A; Cömert S Eur J Pediatr; 2023 Nov; 182(11):4939-4947. PubMed ID: 37606703 [TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening. Lee JM; Kodsi SR; Gaffar MA; Rubin SE J AAPOS; 2014 Apr; 18(2):183-4. PubMed ID: 24698618 [TBL] [Abstract][Full Text] [Related]
13. The pain response to mydriatic eyedrops in preterm infants. Cohen AM; Cook N; Harris MC; Ying GS; Binenbaum G J Perinatol; 2013 Jun; 33(6):462-5. PubMed ID: 23238569 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations. Neffendorf JE; Mota PM; Xue K; Hildebrand GD Eur J Ophthalmol; 2015; 25(3):249-53. PubMed ID: 25449644 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial. Seliniotaki AK; Lithoxopoulou M; Talimtzi P; Georgiou E; Diamanti E; Ziakas N; Haidich AB; Mataftsi A J Perinatol; 2022 Mar; 42(3):371-377. PubMed ID: 34654903 [TBL] [Abstract][Full Text] [Related]
16. Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants. Dincer E; Gonen I; Bornaun HA; Yasa B; Babayigit A; Kurum O; Bayramoğlu SE; Cetinkaya M Am J Perinatol; 2024 May; 41(S 01):e324-e330. PubMed ID: 35714652 [TBL] [Abstract][Full Text] [Related]
17. Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure. Agrawal Y; Patri S; Kalavakunta JK; Gupta V BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27469387 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial. Seliniotaki AK; Haidich AB; Lithoxopoulou M; Gika H; Boutou E; Virgiliou C; Nikolaidou M; Dokoumetzidis A; Raikos N; Diamanti E; Ziakas N; Mataftsi A Trials; 2022 Apr; 23(1):322. PubMed ID: 35428316 [TBL] [Abstract][Full Text] [Related]
19. Topical phenylephrine may result in worsening of visual loss when used to dilate pupils in patients with vaso-occlusive disease of the optic nerve. Pless M; Friberg TR Semin Ophthalmol; 2003 Dec; 18(4):218-21. PubMed ID: 15513009 [TBL] [Abstract][Full Text] [Related]
20. Atrial arrhythmia after newborn eye exam, to caffeine or not to caffeine? Ahmad A; Mondal T; Klein B J Neonatal Perinatal Med; 2016; 9(4):427-431. PubMed ID: 28009338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]